| Literature DB >> 27718257 |
Rawi Ramautar1, Govert W Somsen2, Gerhardus J de Jong3.
Abstract
CE-MS can be considered a useful analytical technique for the global profiling of (highly) polar and charged metabolites in various samples. Over the past few years, significant advancements have been made in CE-MS approaches for metabolomics studies. In this paper, which is a follow-up of a previous review paper covering the years 2012-2014 (Electrophoresis 2015, 36, 212-224), recent CE-MS strategies developed for metabolomics covering the literature from July 2014 to June 2016 are outlined. Attention will be paid to new CE-MS approaches for the profiling of anionic metabolites and the potential of SPE coupled to CE-MS is also demonstrated. Representative examples illustrate the applicability of CE-MS in the fields of biomedical, clinical, microbial, plant, and food metabolomics. A complete overview of recent CE-MS-based metabolomics studies is given in a table, which provides information on sample type and pretreatment, capillary coatings, and MS detection mode. Finally, general conclusions and perspectives are given.Entities:
Keywords: Biomedical and clinical; Food; Metabolomics; Microbial and plant; Technological developments
Mesh:
Substances:
Year: 2016 PMID: 27718257 PMCID: PMC5248609 DOI: 10.1002/elps.201600370
Source DB: PubMed Journal: Electrophoresis ISSN: 0173-0835 Impact factor: 3.535
Figure 1Performance of CE–MS using a sheathless porous tip sprayer for anionic metabolic profiling. Multiple extracted ion electropherograms for the metabolite test mixture (25 μM) obtained with sheathless CE–MS in negative‐ion mode using a porous tip sprayer. Peaks: 1, 2‐Naphtol‐3,6‐disulfonic acid; 2, d(+)2‐phosphoglyceric acid; 3, d‐ribose‐5‐phosphate; 4, d‐glucose‐1‐phosphate; 5, d‐glucose‐6‐phosphate; 6, d‐fructose‐6‐phosphate; 7, inosine 5’‐monophosphate (IMP); 8, guanosine 3’,5’‐cyclic monophosphate (cGMP); 9, guanosine 5’‐monophosphate; 10, citric acid; 11, trimesic acid; 12, isocitric acid; 13, gluconic acid; 14, adenosine 3’,5’‐cyclic monophosphate (cAMP); 15, 2‐hydroxybutyric acid; 16, b‐diphosphopyridine nucleotide (NAD+); 17, 3‐hydroxybutyric acid. Experimental conditions: BGE, 10% acetic acid (pH 2.2); separation voltage, −30 kV (+0.5 psi applied at the inlet of the CE capillary); sample injection, 2.0 psi for 60 s. Reproduced from 32 with permission.
Figure 2Extracted ion electropherograms obtained with CE–MS using a coaxial sheath‐liquid nanospray interface and a large volume sample injection for (A) nucleotide standards (500 ng/L) and (B) AMP (m/z 346.056), (C) ADP (m/z 426.022), (D) GDP (m/z 442.017), (E) ATP (m/z 505.989), and (F) GTP (m/z 521.983) nucleotides detected in an extract of an individual neuron from the sea slug Aplysia californica. Experimental conditions: BGE, 20 mM ammonium bicarbonate (pH 10); injection volume, 100 nL; separation voltage, +10 kV. Reproduced from 29 with permission.
Figure 3Extracted ion electropherograms obtained with sheath‐liquid CE–MS using a cationic capillary coating for an anionic metabolit mixture containing ATP (0.3 mM), nicotinic acid (7.8 mM), glutamic acid (0.5 mM), aspartic acid (1.0 mM), glutathione oxidized (0.3 mM), glutathione reduced (0.6 mM), iminodiacetic acid (2.7 mM), AMP (0.2 mM), panthotenic acid (0.2 mM), succinic acid (1.4 mM), gluconic acid (0.1 mM), hippuric acid (0.4 mM), malic acid (0.3 mM), citric acid (0.2 mM), tartaric acid (0.2 mM), and 1,4 piperazinediethanesulfonic acid (2.8 mM). Experimental conditions: CE analysis at reverse polarity (−20 kV); BGE, 1 M formic acid (pH 2.4); sample injection, 35 mbar for 80 sec. Reproduced from 33 with permission.
Overview of CE–MS‐based metabolomics studies reported between July 2014 and June 2016
| Compounds | Sample matrix | BGE | Sample pretreatment | MS analyzer | LOD | Remarks | Ref. |
|---|---|---|---|---|---|---|---|
| Non‐targeted applications | |||||||
| Anionic metabolites | Rat urine | 25 mM triethylamine | Dilution with BGE (1:1, v/v) | TOF | 0.7–9.1 μM |
| |
| Cationic metabolites | Human breast milk | 3 M formic acid | Folch extraction; dried extract dissolved in 20 mM formic acid, followed by centrifugation. | TOF | n.s. |
| |
| Anionic metabolites | Glioblastoma cells | 10% acetic acid (pH 2.2) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | 10–200 nM | Low‐pH BGE for anionic metabolic profiling; porous tip sheathless interface |
|
| Cationic metabolites | Orange juice and red wine | 1 M formic acid (pH 2.4) | Filtration using 0.2 μm polyethersulfone filter | TOF | 0.1–16.4 ppm | Cationic polymer coating for anionic metabolic profiling |
|
| Cationic metabolites | Mouse plasma | 50 mM acetic acid and 50 mM formic acid (pH 3.5) | Cold acetonitrile for protein precipitation followed by centrifugation | TOF | n.s. | C18 sorbent for in‐line SPE‐CE |
|
| Cationic metabolites | Colon cancer cells | 3 M formic acid | Water for extraction of intracellular metabolites; cell debris separated by centrifugation | TOF | n.s. |
| |
| Anionic and cationic metabolites | Human serum | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling; internal standards for quantification |
|
| Cationic metabolites | Human urine | 0.1 M formic acid | Centrifugation and fivefold dilution with separation buffer | TOF | n.s. |
| |
| Cationic metabolites | Mouse plasma | 10% acetic acid (pH 2.2) | Cold ethanol for protein precipitation; supernatant evaporated; dried extract reconstituted in 100 mM ammonium acetate (pH 4.0) | TOF | low nM‐range | Neutral coated capillary for separation; porous tip sheathless interface |
|
| Cationic metabolites | Human plasma | 1 M formic acid (pH 1.8) containing 15% acetonitrile | Plasma diluted fourfold with ammonium acetate (pH 5.0); proteins removed using 3‐kDa filter | TOF | n.s. | Multi‐segment injection; internal standard for quantification |
|
| Anionic and cationic metabolites | Tobacco leaves | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water phase filtered with 5‐kDa ultrafiltration membrane followed by evaporation and reconstitution in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling; internal standards for quantification |
|
| Anionic and cationic metabolites |
| 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Cationic metabolites |
| 0.8 M formic acid containing 10% methanol | Cold methanol/water extraction; supernatant evaporated and reconstituted in water | TOF | n.s. |
| |
| Anionic and cationic metabolites | Porcine muscle | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Colorectal cancer tissues | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Mouse serum and placenta | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Rat and human serum | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Tumor tissues | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Human plasma | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Skeletal muscle | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Rat stomach and serum | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Mouse plasma | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Human plasma and serum | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Anionic and cationic metabolites | Fetal hepatocytes | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Cationic metabolites | Human serum | 0.8 M formic acid containing 10% methanol | Formic acid/acetonitrile extraction; supernatant ultrafiltrated with 30 kDa‐filter | TOF | n.s. |
| |
| Anionic and cationic metabolites | Mouse astrocytes | 50 mM ammonium acetate (pH 8.5); 1 M formic acid (pH 1.8) | Methanol/water/chloroform extraction; methanol/water layer evaporated; dried extract reconstituted in water | TOF | n.s. | Normal CE separation polarity for anionic metabolic profiling |
|
| Cationic metabolites | Embryonic cells | 1% M formic acid | Methanol/water containing 0.5% acetic acid for extraction | TOF | low nM‐range | Low‐flow sheath‐liquid interface |
|
| Targeted | |||||||
| Nucleotides |
| 20 mM ammonium bicarbonate (pH 10) | Cold methanol/ammonium bicarbonate (1:1) extraction | TOF | 2–22 nM | Low flow sheath‐liquid interface |
|
| Methylcytosine and hydroxyl‐methylcytosine | Genomic DNA | 10% acetic acid (pH 2.2) | Genomic DNA digested; Ultrafiltration with 10‐kDa filter | Triple quadrupole | 50–100 pM | Porous tip sheathless interface |
|
LOD, S/N = 3; ns, not specified in paper.
Figure 4Metabolic profiles obtained by sheath‐liquid CE–MS for three different human urine samples. Shown on the left are total ion electropherograms of (A) a 10 mg tar smoker, (B) a 1 mg tar smoker, and (C) a nonsmoking control subject. On the right are shown the corresponding molecular features extracted from the same 10 mg tar smoker (3395 features), 1 mg tar smoker (3125 features), and nonsmoking (2362 features) urine samples. Experimental conditions: BGE, 0.1 M formic acid; injection volume: 3 nL; separation voltage, +30 kV. Reproduced from 40 with permission.
Figure 5Base peak electropherogram obtained for a deproteinized mouse plasma sample by CE–MS using a sheathless porous tip interface. Experimental conditions: BGE, 10% acetic acid (pH 2.2); sample injection, 25 nL using transient isotachophoresis; separation voltage, +25 kV. Reproduced from 41 with permission.
Figure 6Metabolites identified by CE–MS and GC–MS in a pooled extract of tobacco leaves. (A) Venn diagram of the identified metabolites based on GC–MS and CE–MS. (B) Specific compounds identified by the two platforms. (C) Metabolites that were uniquely detected by CE–MS (red) and GC–MS (blue). Reproduced from 45 with permission.